Product
Mesenchymal Stem Cell (MSC) therapy
1 clinical trial
1 indication
Indication
Bronchopulmonary DysplasiaClinical trial
Clinical Trial: Security and Feasibility of Mesenchymal Stem Cell Therapy in Treatment and Prevention of Bronchopulmonary Dysplasia in Preterm BabiesStatus: Completed, Estimated PCD: 2020-04-02